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Asthma is a heterogeneous disease, usually 
characterized by chronic airway inflammation. It is 
defined by the history of respiratory symptoms such 
as wheeze, shortness of breath, chest tightness and 
cough that vary over time and in intensity, together 
with variable expiratory airflow limitation.1 Trace 
elements are essential micronutrients that exist in 
very low concentrations in the body, forming less 
than 0.01% of the total body weight. They play an 
important role in various physiological processes, 
and are crucial for proper functioning of the 
immune system. 
Deficiency of trace elements and infectious 
diseases are often concomitantly observed and 
result in complex interactions.2 This is mainly due 
to the fact that these elements are part of the 
structure of antioxidant enzymes. These enzymes 
act as antioxidant defense and are able to regulate 
the host immune system, and alter viral genome. 
There is increasing evidence that reactive oxygen 
species can be of particular importance in the 
pathophysiology of several lung diseases.3 The 
antioxidant mechanisms that protect the lung 
against these oxidants include: superoxide 
dismutases (SODs) and Glutathione peroxidase 
(GSH-Px). GSH-Px has selenium component and 
the super oxide dismutases have copper and zinc 
components in their structure. Changes in the level 
of these trace elements decrease the efficiency of 
antioxidant systems and this leads to hyper-
reactivity and inflammation in the respiratory tract.4 
The epidemiology of pediatric asthma and that of 
lead poisoning are strikingly similar. Published 
analyses suggest that lead exposure may result in 
alterations to immune system components known to 
be associated with asthma. Blood lead levels ≥0.48 
pmol/L (10 microg/ dL) has been associated with 
the increased production of total immunoglobulin E 
(IgE), which is also observed in atopic and 
nonatopic individuals with asthma.5 
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Background: Copper and lead are trace elements required for the activity of 
antioxidant enzymes and changes in their levels may lead to reduction in 
antioxidant activities in asthma.  
Objective: Our study aims to investigate the serum levels of copper and lead 
in asthmatic children in correlation to disease severity to anticipate their 
role as oxidant defenders in this disease.  
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group. Patients were subjected to: history taking, clinical examination, 
spirometry before and after bronchodilator therapy, complete blood 
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All the mechanisms mentioned above suggest 
that copper and zinc are important elements in 
oxidant/antioxidant path ways and therefore have a 
critical role in patients with BA. A number of 
studies reported have shown the association and or 
correlation between serum trace elements and 
asthma disease.6 With this as a background, we 
aimed to investigate the serum levels of copper and 
lead in asthmatic children in correlation to disease 
severity to anticipate their role as oxidant defenders 
in this disease. 
 
METHODS 
This is a cross sectional controlled study that was 
conducted at the specialized Pediatric Chest Clinics 
of Benha and Zagazig University Hospitals during 
the period from March 2014 to June 2014. Two 
groups of subjects were enrolled; group 1 included 
30 children above 5 years of age having physician 
diagnosed bronchial asthma during disease 
quiescence.  
The diagnosis was verified according to the 
Global Initiative for Asthma (GINA) Guidelines for 
Asthma Severity and Control7 after consideration of 
the exclusion criteria which include receiving 
systemic corticosteroid treatment during the last 
month; chronic illness involving liver, kidney 
disease or thyroid dysfunction; and uncontrolled 
asthma. Group 2 included 15 clinically healthy 
children without personal or family history of 
asthma or other allergic conditions. The study 
gained approval of local ethical committee of the 
Pediatric Department, Benha University. Informed 
written consent was obtained from the parents or 
care givers of enrolled children after explanation of 
the study. 
Methods: 
Enrolled patients were subjected to full history 
taking with special attention to intermittent attacks 
of cough, expectoration, wheezy dyspnea and chest 
tightness. Detailed physical examination was 
performed including tachypnea, signs of 
hyperinflation, prolonged expiratory phase and 
expiratory rhonchi. Evaluation of lung functions by 
Spirometry (performed by Erich jaejre 95 GmbH 
1992-1997 for measurement of pulmonary function) 
were performed before and after bronchodilator 
(administration of four separate puffs at 30-second 
intervals of the short acting B2-agonist salbutamol 
(total of 400 mcg) using a spacer device) 8 with 
measuring the following indices: Forced vital 
capacity (FVC), forced expiratory volume in 1st 
second (FEV1) and FEV1/FVC and post 
bronchodilator change in FEV1 which are displayed 
automatically by the apparatus. 
Laboratory investigations were done for all 
enrolled subjects including complete blood count 
analyzed by sysmex Kx-21N with microscopic 
manual differential count, total serum IgE level 
measurement by ELISA (DiaMed Eurogen, 
Turnhout, Belgium) and determination of serum 
levels of copper and lead using Perkin-Elmer 2380, 
USA atomic absorption spectrophotometer. 
 
Statistical analysis: 
Data were tabulated, coded then analyzed using the 
computer program SPSS (statistical package for 
social science) version 16. Quantitative data were 
presented as mean ± SD. Student t-test was used to 
compare between two groups. Pearson’s correlation 
coefficient was used to test correlation between 
variables and chi-square test was used to compare 
frequency of qualitative variables among the 
different groups. For all analyses, the level of 
significance was set at p < 0.05.  
 
RESULTS 
The current study included 30 asthmatic children 
and 15 matched healthy children as a control group. 
Their clinical and demographic data are shown in 
table (1). Patients pulmonary function parameters 
are depicted in table (2). Concerning grades of 
asthma severity; there were 12 cases (40%) with 
mild persistent asthma, 15 cases (50%) with 
moderate persistent asthma and 3 cases (10%) with 
intermittent asthma. In comparison to controls, 
patients had significantly higher serum total IgE 
and hemoglobin levels and higher eosinophils count 
(table 3). Patients’ group showed significantly 
higher serum levels of lead and copper in 
comparison to controls (table 4). Among enrolled 
patients, serum lead and copper levels were higher 
among those with moderate persistent asthma in 
comparison to patients with mild asthma (table 6). 
However, serum lead and copper levels did not 
correlate with any of the measured pulmonary 
function parameters tested (table 7).  
Serum total IgE levels correlated positively with 
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Table 2. Pulmonary function test results among enrolled patients. 
Variable (No.=30) Mean± SD Range 
FEV1% 76.9±8.1 60-90 
FVC% 81.4±9.9 60-98 
FEV1/FVC 82.8±4.8 76-90 
Percentage of change in FEV1 post bronchodilator 15± 2.3 13-20 










(No.=15) Test p -value 
mean± SD Range mean± SD Range 
IgE (IU/ml) 471.2±484.8 32-1920 86.5±44.4 44-176 z= 3.49 <0.001 (HS) 
Eosinophils count 
(cells per microliter) 
320±170 100-570 112±25 65-126 z= 4.79 <0.001 (HS) 
HB (g/dl) 11.7±1.0 9.6-13.7 10.8±1.0 9.2-12.5 t=2.80 0.008 (S) 









(No.=15) t-test p-value 
Mean ± SD Range Mean ± SD Range 
Serum lead (μg/dl) 8.2±3.1 2.3-12 5.7±2.3 2.1-9.6 2.75 0.01 (S) 








r p r p 
IgE (Iu/ml) 0.40 0.03 (-) 0.01 0.94 
Eosinophils (cells/mcL). 0.45 0.03 0.09 0.58 
HB (g/dl) 0.06 0.73 (-) 0.23 0.21 
IgE: immunoglobulin E, HB: hemoglobin 
 
 




Table 6. Variation of serum lead and copper levels according to asthma severity grades. 
Variable (No.=30) 
Serum lead (μg/dl) Serum copper (μg/dl) 
mean± SD F P mean± SD F P 
Asthma severity 
Mild persistent (n=12) 












Table 7. Correlation between serum lead and copper levels and pulmonary function test parameters among 
the asthmatic children. 
Variable (No.=30) 
Lead Copper 
r p r p 
FEV1% (pre-bronchodilator) 0.08 0.67 0.05 0.78 
FVC %(pre-bronchodilator) (-) 0.02 0.93 0.05 0.79 
FEV1/FVC (pre-bronchodilator) 0.10 0.61 (-) 0.09 0.62 
FEV1% (post-bronchodilator) * (-) 0.07 0.74 (-) 0.11 0.63 
FEV1%: forced expiratory volume in the first second percent predicted, FVC%: forced vital capacity percent predicted 
 
DISCUSSION 
Different studies have suggested that trace elements 
such as lead, zinc and copper might be involved in 
acute and chronic inflammatory diseases such as 
bronchial asthma. Furthermore, zinc and copper are 
required for optimal activity of the immune 
system.9 We sought to investigate serum copper and 
lead levels among children with bronchial asthma in 
comparison to matched healthy controls to 
investigate if these elements are related to asthma in 
the pediatric age group. In our study, eosinophils 
count was significantly higher among patients in 
comparison to control group. This result is 
supported by study of Fahy, who found that 
increased numbers of eosinophils in peripheral 
blood and in airway secretion are a characteristic 
feature of asthma. Moreover, patients with more 
severe asthma differ from patients with mild asthma 
in having more eosinophils in their peripheral blood 
and in their airways.10 In contrast, Wenzel et al, 
have pointed out that not all patients with severe 
asthma have airway eosinophilia.11 
The current study revealed significant increase 
in the total serum IgE levels in asthmatic patients 
compared to control group. In a study done by 
Kovac et al, they reported that asthmatic children 
with higher asthma severity have higher serum 
concentration of both total IgE (>288.0kIU/L) and 
specific IgE to Dermatophagoides pteronyssinus 
(>44.1 kIUA/L).12 
In the present study, hemoglobin level was 
significantly lower among studied asthmatic 
children when compared to control group. This was 
in agreement with Ramakrishnan and Borade, who 
found that anemic children are 5.75 times more 
susceptible to develop childhood asthma compared 
to the non-anemic children.13 This may be 
explained by that in anemic persons tidal volume is 
decreased while reserve volumes increase or remain 
unchanged, however total lung capacity markedly 
decreases in these subjects suffering from anemia. 
Weakness of accessory muscles of respiration adds 
to a decrease in Peak expiratory flow rate, forced 
expiratory volume in one second (FEV1). 
Maximum voluntary ventilation is markedly 
reduced due to the decreased depth of respiration as 
well. Anemia leads to decreased pulmonary 
functions which further hampers the oxygenation of 
the tissue and may worsen the physical and mental 
capabilities.14 Serum lead and copper levels were 
significantly higher among enrolled patients in 
comparison to controls; however the mean value of 
lead level (8.2±3.1μg/dl) was below the toxic level 
(toxic levels are those above 10 μg/dl).15 These 
results probably reflect that high lead level might be 
a result rather than an etiopathogenic factor in 
asthma. It may also represent one of potential risk 
factors for persistent bronchial asthma. Increased 
blood lead level can damage the structure of 
bronchial mucosa, which causes chronic 
inflammation and bronchial hyper responsiveness; 
at the same time, a wide range of toxic effects of 
lead can affect the function of the body defense 
system, in particular, inhibiting the T lymphocyte 
functions, which lead to imbalance between Th1 
cell and Th2 cell. Increased blood Lead can also 
increase the level of serum IL-4 levels and serum 
IgE levels, which lead to the increased incidence of 
bronchial asthma.6 Joseph et al, reported that among 
African Americans, blood lead level (BLL) ≥ 5 and 
BLL ≥ 10 μg/dL were not associated with asthma. 
The association of BLL ≥ 5 μg/dL with asthma 
among Caucasians was slightly elevated, but not 
significant [adjusted hazard ratio = 1.4; 95% 
confidence interval (CI), 0.7–2.9; p =0.40] and they 
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stated that the racial differences observed illustrate 
the need for further exploration of the role of race in 
the interrelationships between genetic 
susceptibility, socio environmental exposures, and 
risk of asthma. Lead exposure may be associated 
with excessive production of immunoglobulin E, 
possibly increasing asthma risk and contributing to 
racial disparities.16 On the other hand, a previous 
study reported that there was no significant 
association between lead poisoning even in blood 
lead level 25 μg/dl and asthma diagnosis or asthma 
symptoms.17 El-Kholy et al, studied Zinc and 
copper status in children with bronchial asthma and 
atopic dermatitis and found a significant increase in 
serum and hairs copper in both allergic groups 
compared to the controls. Mean serum and hair 
copper values were 79.5 ± 8.06 μg/100 ml and 18.7 
± 1.9 μg/gm respectively in asthmatic cases, and 
81.4 ± 8.4 μg/100 ml and 17.8 ± 2.08 μg/gm in 
cases with atopic dermatitis. The control mean 
serum and hair concentrations were 67.95 ± 6.37 
μg/100 ml and 14.5 ±2.53 μg/gm respectively.18   
The current study showed that among studied 
patients, total serum IgE levels and eosinophils 
percentage correlated significantly with serum lead 
levels but not serum copper levels. It has been 
proposed that lead acts to increase production of 
IgE through direct or indirect stimulation of B-cells 
or through the binding and subsequent alteration of 
allergens that stimulate the allergenic immune 
response.19 In previous studies, lead has shown a 
positive correlation with IgE levels by acting upon 
IL-4 synthesis (cytokine controlling immuno-
globulin class switch to IgE production) and leading 
to an up- regulation of IgE in B cells.5 Mohammed 
et al, found that elevated blood lead levels among 
patients with asthma was associated with higher 
frequency of eosinophilia and increased total IgE.20  
In the current study there was no statistically 
significant correlation between hemoglobin and 
serum lead levels. The Environmental Protection 
Agency has suggested a threshold lead level of 20–
40 μg/dl for a decrease in hemoglobin in children.21 
Our study does not contradict their report as all of 
our studied children had serum lead level not 
exceeding 20 μg/dl. 
In the present study there was significant 
difference between different asthma grades 
regarding serum lead and copper levels, however 
there was no significant correlation between serum 
lead and copper levels and pulmonary function test 
parameters. Mohammed et al, found that elevated 
blood lead levels among patients with asthma was 
associated with increase in the severity of asthma 
compared to the patients with asthma with blood 
lead level <10μg/dL and several authors concluded 
that although elevated blood lead level had no 
significant correlation with asthma diagnosis, it was 
significantly associated with increased asthma 
severity.20 
Our results did not show clear relation between 
serum lead levels and pulmonary function test 
parameters, mostly due to the fact that most of our 
enrolled patients’ blood lead levels were below10 
μg/dl so the effect was not clear. Larger study 
samples and inclusion of patients with severe 
persistent or uncontrolled asthma might show more 
prominent effect of lead and copper levels on 
asthma disease severity and control and their impact 
on the required inhaled steroid dose. 
 
CONCLUSION 
Increased serum levels of lead and copper may be 
associated with bronchial asthma in children and 
might correlate with disease severity. The 
conclusions are limited by the sample size 
especially of the control group. The lack of local 
reference levels is another limiting factor. Further 
wider scale studies are needed for better assessment 
of these trace elements’ status in childhood asthma 
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